How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus Go to Publication You Might Also Like Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016 India’s multidrug-resistant tuberculosis crisis. December 29, 2001 Tuberculosis control in India. September 3, 2003 Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis September 3, 2020 Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai. October 30, 2014
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis September 3, 2020
Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai. October 30, 2014